#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelin oligodendrocyte glycoprotein antibody-associated disease Non-Hodgkin's lymphoma refractory Angiosarcoma metastatic Synovial sarcoma metastatic Cystic fibrosis respiratory infection suppression Chronic graft versus host disease in skin Primary immunodeficiency syndrome Endometrial cancer Leber's congenital amaurosis Toxic epidermal necrolysis Retinitis pigmentosa Myotonia Prolymphocytic leukaemia Squamous cell carcinoma of the vulva Congenital generalised lipodystrophy More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Trials in Disease Haemolytic uraemic syndrome – Trials in Disease Ewing’s sarcoma recurrent – Trials in Disease Medulloblastoma recurrent Methylmalonic acidaemia – Diagnostics Idiopathic pulmonary fibrosis Uterine leiomyosarcoma – Basic Information Alport’s syndrome – Life with Disease Primary hyperoxaluria – Life with Disease Antisynthetase syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tryptophan Narsoplimab Clodronate Disodium RP3 Atomoxetine Heparin Calcium Aficamten SELTOREXANT Voclosporin R2R01 Art6043 Ubamatamab Peginterferon Beta-1A Calcium Polystyrene Sulfonate Wt1 Mrna Dc Dornase Alfa Tretinoin Thiopental Sodium 68Ga-Nota-Abscint-Her2 Botulinum Toxin Type A More therapies…

    Learn about Your Condition

    Glioblastoma Herpes simplex meningitis Synovial sarcoma recurrent Menopausal symptoms Neuralgia Soft tissue sarcoma Hand fracture Cardiac failure congestive Abdominal infection Polycystic ovarian syndrome Graft infection Pulmonary alveolar haemorrhage Noninfective chorioretinitis Testicular leiomyosarcoma Cholecystitis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. City Clinic Research Sp. z o.o.

City Clinic Research Sp. z o.o.

Ul. Popularna 62a, Warsaw, 02-473, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Riluzole
    Italy The Netherlands Poland Spain

  • Study of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Sodium Cromoglicate
    Czechia Germany Poland Spain

  • Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Dazucorilant
    Belgium France Germany Ireland The Netherlands Poland +1

  • A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

    Recruiting

    3 1 1
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Czechia France Germany Poland Spain

  • Study on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • VHB937
    Belgium Denmark Finland France Germany Ireland +5

  • Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

    Not recruiting

    2 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Utreloxastat
    Belgium Czechia France Germany Ireland Italy +5

  • Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Phenylbutyrate
    • Ursodoxicoltaurine
    Belgium France Germany Ireland Italy The Netherlands +4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!